{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:44:57Z","timestamp":1789155897765,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:00:00Z","timestamp":1720137600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","celltherapyjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jcyt.2024.07.002","type":"journal-article","created":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T22:22:57Z","timestamp":1720304577000},"page":"1514-1521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Chronic liver disease after allogeneic hematopoietic cell transplantation"],"prefix":"10.1016","volume":"26","author":[{"given":"Baljit","family":"Randhawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki","family":"Blosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7884-9122","authenticated-orcid":false,"given":"Jan","family":"Storek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel-Aziz","family":"Shaheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kareem","family":"Jamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jcyt.2024.07.002_bib0001","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.bbmt.2011.12.519","article-title":"Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation","volume":"18","author":"Majhail","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jcyt.2024.07.002_bib0002","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1182\/blood-2017-03-725671","article-title":"How I monitor long-term and late effects after blood or marrow transplantation","volume":"130","author":"Bhatia","year":"2017","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jcyt.2024.07.002_bib0003","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.bbmt.2018.03.023","article-title":"ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors","volume":"24","author":"Hashmi","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jcyt.2024.07.002_bib0004","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3324\/haematol.2016.150250","article-title":"Late effects of blood and marrow transplantation","volume":"102","author":"Inamoto","year":"2017","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.jcyt.2024.07.002_bib0005","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.bbmt.2013.04.002","article-title":"Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study","volume":"19","author":"Sun","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jcyt.2024.07.002_bib0006","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1055\/s-2008-1040578","article-title":"Liver disease after human marrow transplantation","volume":"7","author":"McDonald","year":"1987","journal-title":"Semin Liver Dis"},{"issue":"4","key":"10.1016\/j.jcyt.2024.07.002_bib0007","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1002\/hep.23533","article-title":"Hepatobiliary complications of hematopoietic cell transplantation, 40 years on","volume":"51","author":"McDonald","year":"2010","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.jcyt.2024.07.002_bib0008","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1182\/blood.V93.10.3259.410k13_3259_3266","article-title":"Cirrhosis of the liver in long-term marrow transplant survivors","volume":"93","author":"Strasser","year":"1999","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jcyt.2024.07.002_bib0009","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/sj.bmt.1702532","article-title":"Long-term liver dysfunction after allogeneic bone marrow transplantation: clinical features and course in 61 patients","volume":"26","author":"Tomas","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 1","key":"10.1016\/j.jcyt.2024.07.002_bib0010","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0168-8278(99)80384-5","article-title":"Hepatitis C virus and blood transfusion: past and present risks","volume":"31","author":"van der Poel","year":"1999","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jcyt.2024.07.002_bib0011","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/trf.13024","article-title":"Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions","volume":"55","author":"Bruhn","year":"2015","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.jcyt.2024.07.002_bib0012","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2468-1253(21)00472-6","article-title":"Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study","volume":"7","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jcyt.2024.07.002_bib0013","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1182\/hematology.2019000036","article-title":"Iron overload in transfusion-dependent patients","volume":"2019","author":"Coates","year":"2019","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"9","key":"10.1016\/j.jcyt.2024.07.002_bib0014","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.jcyt.2024.07.002_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2011.03.020","article-title":"Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008","volume":"9","author":"Younossi","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jcyt.2024.07.002_bib0016","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/apt.13012","article-title":"Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey","volume":"41","author":"Ruhl","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.jcyt.2024.07.002_bib0017","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jcyt.2024.07.002_bib0018","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatology"},{"issue":"22","key":"10.1016\/j.jcyt.2024.07.002_bib0019","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jcyt.2024.07.002_bib0020","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jhep.2016.09.022","article-title":"Bi-directional analysis between fatty liver and cardiovascular disease risk factors","volume":"66","author":"Ma","year":"2017","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.jcyt.2024.07.002_bib0021","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1182\/blood-2006-10-054080","article-title":"Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation","volume":"110","author":"Tichelli","year":"2007","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.jcyt.2024.07.002_bib0022","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1182\/blood-2012-06-437178","article-title":"Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease","volume":"120","author":"Armenian","year":"2012","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jcyt.2024.07.002_bib0023","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1111\/j.1572-0241.2008.02071.x","article-title":"The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance","volume":"103","author":"Bell","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jcyt.2024.07.002_bib0024","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jcyt.2024.07.002_bib0025","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.24330","article-title":"Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases","volume":"54","author":"Bacon","year":"2011","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1016\/j.jcyt.2024.07.002_bib0026","first-page":"S10","article-title":"Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome","volume":"42","author":"Diabetes Canada Clinical Practice Guidelines Expert","year":"2018","journal-title":"Can J Diabetes"},{"issue":"8","key":"10.1016\/j.jcyt.2024.07.002_bib0027","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.cjca.2021.03.016","article-title":"2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults","volume":"37","author":"Pearson","year":"2021","journal-title":"Can J Cardiol"},{"issue":"9","key":"10.1016\/j.jcyt.2024.07.002_bib0028","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1210\/jc.2011-3213","article-title":"Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline","volume":"97","author":"Berglund","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.jcyt.2024.07.002_bib0029","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41409-023-01992-8","article-title":"Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT)","volume":"58","author":"Mohty","year":"2023","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jcyt.2024.07.002_bib0030","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3324\/haematol.2016.148510","article-title":"Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","volume":"102","author":"Baron","year":"2017","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.jcyt.2024.07.002_bib0031","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/cncr.28444","article-title":"Cardiovascular disease in survivors of hematopoietic cell transplantation","volume":"120","author":"Armenian","year":"2014","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.jcyt.2024.07.002_bib0032","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000495698","article-title":"Diabetes and metabolic syndrome in survivors of childhood cancer","volume":"91","author":"Friedman","year":"2019","journal-title":"Horm Res Paediatr"},{"issue":"9","key":"10.1016\/j.jcyt.2024.07.002_bib0033","article-title":"Metabolic syndrome in male survivors of pediatric allogeneic hematopoietic stem cell transplantation: impact of total body irradiation, low-grade inflammation, and hypogonadism","volume":"27","author":"Muhic","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"7","key":"10.1016\/j.jcyt.2024.07.002_bib0034","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/gutjnl-2020-322786","article-title":"Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort","volume":"70","author":"Simon","year":"2021","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.jcyt.2024.07.002_bib0035","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.jcyt.2024.07.002_bib0036","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1161\/ATV.0000000000000153","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American Heart Association","volume":"42","author":"Duell","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"14","key":"10.1016\/j.jcyt.2024.07.002_bib0037","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease","volume":"363","author":"Targher","year":"2010","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jcyt.2024.07.002_bib0038","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cgh.2011.01.023","article-title":"Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma","volume":"9","author":"Yasui","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"26","key":"10.1016\/j.jcyt.2024.07.002_bib0039","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1182\/blood.2018874115","article-title":"Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation","volume":"133","author":"Baker","year":"2019","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jcyt.2024.07.002_bib0040","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/bloodadvances.2020003910","article-title":"Cumulative incidence of subsequent malignancy after allo-HCT conditioned with or without low-dose total body irradiation","volume":"6","author":"Nunez","year":"2022","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.jcyt.2024.07.002_bib0041","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.bbmt.2016.12.623","article-title":"Cardiovascular risk factors in survivors of childhood hematopoietic cell transplantation treated with total body irradiation: a longitudinal analysis","volume":"23","author":"Friedman","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.07.002_bib0042","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4344905","article-title":"Glucocorticosteroids and the risk of NAFLD in inflammatory bowel disease","volume":"2022","author":"Jarmakiewicz-Czaja","year":"2022","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.jcyt.2024.07.002_bib0043","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jsbmb.2015.07.020","article-title":"Glucocorticoids and non-alcoholic fatty liver disease","volume":"154","author":"Woods","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"4","key":"10.1016\/j.jcyt.2024.07.002_bib0044","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/bmt.2014.313","article-title":"Older recipient age is paradoxically associated with a lower incidence of chronic GVHD in thymoglobulin recipients: a retrospective study exploring risk factors for GVHD in allogeneic transplantation with thymoglobulin GVHD prophylaxis","volume":"50","author":"Lim","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jcyt.2024.07.002_bib0045","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jhep.2019.03.033","article-title":"Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease","volume":"71","author":"Srivastava","year":"2019","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jcyt.2024.07.002_bib0046","doi-asserted-by":"crossref","first-page":"E370","DOI":"10.9778\/cmajo.20200009","article-title":"Risk stratification of patients with nonalcoholic fatty liver disease using a case identification pathway in primary care: a cross-sectional study","volume":"8","author":"Shaheen","year":"2020","journal-title":"CMAJ Open"},{"issue":"3","key":"10.1016\/j.jcyt.2024.07.002_bib0047","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7570\/jomes23052","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review","volume":"32","author":"Chan","year":"2023","journal-title":"J Obes Metab Syndr"},{"key":"10.1016\/j.jcyt.2024.07.002_bib0048","article-title":"Management of hepatitis B virus in allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Wu","year":"2020","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.jcyt.2024.07.002_bib0049","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3324\/haematol.2008.002048","article-title":"Hepatitis C virus and allogeneic stem cell transplantation still matters!","volume":"94","author":"Socie","year":"2009","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.jcyt.2024.07.002_bib0050","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11886-024-02025-6","article-title":"The global epidemic of metabolic fatty liver disease","volume":"26","author":"Lee","year":"2024","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.jcyt.2024.07.002_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2024.03.006","article-title":"The global epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among patients with type 2 diabetes","author":"Younossi","year":"2024","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324924007722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324924007722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T10:05:16Z","timestamp":1731405916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324924007722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1465324924007722"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2024.07.002","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic liver disease after allogeneic hematopoietic cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2024.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society for Cell & Gene Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}